Enrichment method of multi-target specific deoxyribonucleic acid aptamers
CN103421738A
Pharmacy applications of MTA1 and inhibitor thereof
CN103374072A
Preparation of anti-Mac-2BP humanized antibody
CN103374071A
Preparation of anti-DERLIN-1 humanized antibody
CN102676650A
Application of quantitative detection of CPT1A gene or protein in prognosis of esophageal squamous cell carcinomas
CN103160467A
A poorly differentiated thyroid cancer cell line PDTC-1 and applications thereof
CN102676516A
New use of microRNA 145
WO2012025057A1
Use of il-23 in early stage diagnosis of liver cancer
CN102676453A
Method for culturing natural killer (NK) and/or natural killer T (NKT) cells
CN102321173A
Humanized macrophage inhibitory factor 1 monoclonal antibody and application thereof
CN102675677A
Application of PCL-g-PGMA (polycaprolactone-graft-polyglycidyl methacrylate)/gelatin composite material in cell transfection
CN102675676A
PCL-g-PDMAEMA (polycaprolactone-graft-poly(N,N-dimethylamino-2-ethyl methacrylate)/gelatin composite material and preparation method thereof
CN102675678A
PCL (polycaprolactone)-g-PGMA (poly glyceryl methacrylate)/gelatin composite material and preparation method thereof
CN102670520A
Chemotherapy drug pulse sustained-release implant agent and preparation method thereof
CN102735840A
Reagent for diagnosis or screening of ovarian cancer
CN102735844A
Protein composition and application in preparing lung cancer diagnosis reagent kit
CN102692505A
Improved co-immunoprecipitation technical method
CN102175868A
Application of combined quantitative detection of IL-1[beta], IL-6, IL-10, IL-17, IL-23 and TNF-[alpha] in serum in early-stage prediction of liver cancer
CN102028958A
Composite tumor gene vaccine taking bacterial nano magnetosome as carrier and preparation method thereof
CN102453713A
HULC siRNA and use of HULC siRNA in preparation of drugs for treatment of liver cancer
